Back to Search Start Over

Epidemiological, Clinical, and Genomic Profile in Head and Neck Cancer Patients and Their Families.

Authors :
Chulam TC
Bertonha FB
Villacis RAR
Filho JG
Kowalski LP
Rogatto SR
Source :
Biomedicines [Biomedicines] 2022 Dec 17; Vol. 10 (12). Date of Electronic Publication: 2022 Dec 17.
Publication Year :
2022

Abstract

Inherited cancer predisposition genes are described as risk factors in head and neck cancer (HNC) families. To explore the clinical and epidemiological data and their association with a family history of cancer, we recruited 74 patients and 164 relatives affected by cancer. The germline copy number alterations were evaluated in 18 patients using array comparative genomic hybridization. Two or more first-degree relatives with HNC, tobacco-associated tumor sites (lung, esophagus, and pancreas), or other related tumors (breast, colon, kidney, bladder, cervix, stomach carcinomas, and melanoma) were reported in 74 families. Ten index patients had no exposure to any known risk factors. Family members presented tumors of 19 topographies (30 head and neck, 26 breast, 21 colon). In first-degree relatives, siblings were frequently affected by cancer ( n = 58, 13 had HNC). Breast cancer ( n = 21), HNC ( n = 19), and uterine carcinoma ( n = 15) were commonly found in first-degree relatives and HNC in second-degree relatives ( n = 11). Nineteen germline genomic imbalances were detected in 13 patients; three presented gains of WRD genes. The number of HNC patients, the degree of kinship, and the tumor types detected in each relative support the role of heredity in these families. Germline alterations may potentially contribute to cancer development.

Details

Language :
English
ISSN :
2227-9059
Volume :
10
Issue :
12
Database :
MEDLINE
Journal :
Biomedicines
Publication Type :
Academic Journal
Accession number :
36552033
Full Text :
https://doi.org/10.3390/biomedicines10123278